Print ISSN:-2348-7348

Online ISSN:-2348-7240

CODEN : AGEMCY

Current Issue

Year 2019

Volume: 6 , Issue: 2

Article Access statistics

Viewed: 494

Emailed: 0

PDF Downloaded: 253

Annals of Geriatric Education and Medical Sciences


Melasma like hyperpigmentation on face: A rare side effect of imatinib


Full Text PDF Share on Facebook Share on Twitter


Author Details : Anusha Gupta, Sunil Kumar*, Saurav Chaturvedi, Apoorva Nirmal

Volume : 5, Issue : 2, Year : 2018

Article Page : 79-80


Suggest article by email

Abstract

Imatinib mesylate is a cytotoxic agent that is used in chronic myeloid leukaemia. Common reported side effect is hypopigmentation; here we report a 48 year old female who developed hyperpigmentation as melasma on her face while taking imatinib mesylate in a dose of 400 mg daily for chronic myeloid leukaemia.

Keywords: Drug-induced pigmentation, Imatinib-mesylate, Melasma, Chronic myeloid leukemia.

Doi : 10.18231/2348-7240.2018.0019

How to cite : Gupta A, Kumar S, Chaturvedi S, Nirmal A, Melasma like hyperpigmentation on face: A rare side effect of imatinib. Ann Geriatr Educ Med Sci 2018;5(2):79-80

Copyright © 2018 by author(s) and Ann Geriatr Educ Med Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (creativecommons.org)